Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 5—May 2017
Dispatch

Survey of Treponemal Infections in Free-Ranging and Captive Macaques, 1999–2012

Amy R. Klegarth, Chigozie A. Ezeonwu, Aida Rompis, Benjamin P.Y.-H. Lee, Nantiya Aggimarangsee, Mukesh Chalise, John Cortes, M. Feeroz, Barbara J. Molini, Bess C. Godornes, Michael Marks, Michael Schillaci, Gregory Engel, Sascha Knauf, Sheila A. Lukehart, and Lisa Jones-EngelComments to Author 
Author affiliations: University of Washington, Seattle, Washington, USA (A.R. Klegarth, C.A. Ezeonwu, B.J. Molini, B.C. Godornes, S.A. Lukehart, L. Jones-Engel); Udayana University, Denpasar, Bali, Indonesia (A. Rompis); University of Kent, Canterbury, UK (B.P.Y-H. Lee); Chiang Mai University, Chiang Mai, Thailand (N. Aggimarangsee); Tribhuvan University, Kirtipu, Nepal (M. Chalise); HM Government of Gibraltar, Gibraltar, Gibraltar (J. Cortes); Jahangirnagar University, Dhaka, Bangladesh (M. Feeroz); London School of Hygiene and Tropical Medicine, London, UK (M. Marks); University of Toronto Scarborough, Toronto, Ontario, Canada (M. Schillaci); Samuel Simmonds Memorial Hospital, Barrow, Alaska, USA (G. Engel); German Primate Center, Gottingen, Germany (S. Knauf)

Main Article

Table 2

Treponemal infections in blood samples from free-ranging and pet macaques, by geographic location, 1999–2012*

Location
 No. macaques positive/no. negative (% reactive)†
 No. macaques tested/no. positive‡
Indonesia
Bali 2/155 (1.3) 2/0
Java 0/25 (0) NA
Sulawesi
 8/109 (7.3)
 8/6
Nepal
 0/28 (0)
 NA
Singapore
 1/75 (1.3)
 1/0
Bangladesh
 0/137 (0)
 NA
Thailand
 0/22 (0)
 NA
Cambodia
 0/48 (0)
 NA
Gibraltar
 0/124 (0)
 NA
Total 11/734 (1.5) 11/0

*NA, indicates that samples in the region were not tested.
†Determined by using the Macro-Vue RPR (rapid plasma reagin) test (BD, Franklin Lakes, NJ, USA).
‡Determined by using ESPLINE TP (Fujirebio Inc., Tokyo, Japan), a reagent for the detection of Treponema pallidum antibodies.

Main Article

Page created: April 17, 2017
Page updated: April 17, 2017
Page reviewed: April 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external